[1]郭亚男,杨海波#,赵荫涛,等.可溶性环氧化物水解酶抑制剂在TGF-β1诱导的人脐静脉内皮细胞内皮-间质转化中的作用*[J].郑州大学学报(医学版),2017,(02):163-167.[doi:10.13705/j.issn.1671-6825.2017.02.014]
 GUO Yanan,YANG Haibo,ZHAO Yintao,et al.Effect of soluble epoxide hydrolase inhibitor on endothelial-to-mesenchymal transition of human umbilical vein endothelial cells induced by TGF-β1[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2017,(02):163-167.[doi:10.13705/j.issn.1671-6825.2017.02.014]
点击复制

可溶性环氧化物水解酶抑制剂在TGF-β1诱导的人脐静脉内皮细胞内皮-间质转化中的作用*()
分享到:

《郑州大学学报(医学版)》[ISSN:1671-6825/CN:41-1340/R]

卷:
期数:
2017年02期
页码:
163-167
栏目:
应用研究
出版日期:
2017-03-15

文章信息/Info

Title:
Effect of soluble epoxide hydrolase inhibitor on endothelial-to-mesenchymal transition of human umbilical vein endothelial cells induced by TGF-β1
作者:
郭亚男杨海波#赵荫涛刘 源李 凌周岩强
郑州大学第一附属医院心血管内科 郑州 450052
Author(s):
GUO YananYANG HaiboZHAO YintaoLIU YuanLI LingZHOU Yanqiang
Department of Cardiology, the First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052
关键词:
可溶性环氧化物水解酶抑制剂 内皮-间质转化 脐静脉内皮细胞 心肌纤维化
Keywords:
soluble epoxide hydrolase inhibitor endothelial-to-mesenchymal transition HUVEC myocardial fibrosis
分类号:
R542.2+3
DOI:
10.13705/j.issn.1671-6825.2017.02.014
摘要:
目的:观察可溶性环氧化物水解酶抑制剂t-AUCB对TGF-β1诱导的人脐静脉内皮细胞(HUVEC)内皮-间质转化(EndMT)的影响。方法:采用t-AUCB(50 μmol/L)预处理HUVEC 40 min后,用TGF-β1(10 μg/L)诱导HUVEC 24 h,采用Western blot法检测Smad2/3的磷酸化水平; 诱导72 h后,光镜观察细胞形态的变化,采用CCK-8试剂盒检测细胞活性,采用实时荧光定量PCR检测内皮细胞标记物(CD31)、间质细胞标记物(collagen Ⅰ、 collagen Ⅲ、vimentin)及EndMT中重要的下游转录因子(snail1、twist1、twist2、ZEB1)mRNA的表达。同时设TGF-β1和t-AUCB单独作用组。结果:光镜下,TGF-β1组细胞转变为狭长形,细胞间隙疏松,TGF-β1+t-AUCB组、t-AUCB组细胞形态正常。TGF-β1组细胞CD31 mRNA表达下调,collagen Ⅰ、 collagen Ⅲ、vimentin mRNA表达上调,snail1、twist1、twist2、ZEB1 mRNA表达上调,Smad2及Smad3蛋白磷酸化水平升高(P<0.05)。与TGF-β1组比较,TGF-β1+t-AUCB组、t-AUCB组上述指标的表达均有一定程度的逆转(P<0.05)。结论:t-AUCB可通过抑制内皮细胞的EndMT而发挥抗纤维化作用。
Abstract:
Aim: To observe the effect of soluble epoxide hydrolase inhibitor t-AUCB on TGF-β1 induced endothelial-to-mesenchymal transition(EndMT)of human umbilical vein endothelial cell(HUVEC).Methods: The HUVEC were pretreated by t-AUCB(50 μmol/L)for 40 min,then were induced by TGF-β1(10 μg/L)for 24 h,and Western blot was used to detect the phosphorylation levels of Smad2/3; after 72 h, light microscope was used to observe cell morphology,CCK-8 kit was used to test cell viability, and Real-time PCR was used to determine the mRNA expressions of epithelial marker(CD31)and mesenchymal markers(collagen Ⅰ,collagen Ⅲ,vimentin), as well as the key downstream transcription factors(snail1,twist1,twist2,ZEB1). TGF-β1 group and t-AUCB group were set.Results: The cells in TGF-β1 group changed into a long and narrow shape with intercellular porosis, while the cells in TGF-β1+t-AUCB group and t-AUCB group had normal forms. In TGF-β1 group,CD31 mRNA expression was down-regulated, but those of collagen Ⅰ, collagen Ⅲ, vimentin,snail1,twist1,twist2,and ZEB1 were up-regulated,and Smad2 and Smad3 protein phosphorylation levels in creased(P<0.05). Compared with those of TGF-β1 group, the indexes mentioned above in TGF-β1+t-AUCB group and t-AUCB group showed reversed effect to a certain extent(P<0.05).Conclusion: t-AUCB has an anti-fibrosis effect on the HUVEC by inhibiting the progress of EndMT.

参考文献/References:

[1] VASAN RS,BENJAMIN EJ.Diastolic heart failure:no time to relax[J].N Engl J Med,2001,344(1):56
[2] KRENNING G,ZEISBERG EM,KALLURI R.The origin of fibroblasts and mechanism of cardiac fibrosis[J].J Cell Physiol,2010,225(3):631
[3] BUJAK M,REN G,KWEON HJ,et al.Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling[J].Circulation,2007,116(19):2127
[4] WIDYANTORO B,EMOTO N,NAKAYAMA K,et al.Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition[J].Circulation,2010,121(22):2407
[5] FENG XH,DERYNCK R.Specificity and versatility in tgf-beta signaling through Smads[J].Annu Rev Cell Dev Biol,2005,21(21):659
[6] DAVIS BB,THOMPSON DA,HOWARD LL,et al.Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation[J].Proc Natl Acad Sci USA,2002,99(4):2222
[7] QIN J,SUN D,JIANG H,et al.Inhibition of soluble epoxide hydrolase increases coronary perfusion in mice[J].Physiol Rep,2015,3(6):12427
[8] SHEN L,PENG H,ZHAO S,et al.A potent soluble epoxide hydrolase inhibitor, t-AUCB, modulates cholesterol balance and oxidized low density lipoprotein metabolism in adipocytes in vitro[J].Biol Chem,2014,395(4):443
[9] PORTER KE,TURNER NA.Cardiac fibroblasts: at the heart of myocardial remodeling[J].Pharmacol Ther,2009,123(2):255
[10]SIRISH P,LI N,LIU JY,et al.Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis[J].Proc Natl Acad Sci U S A,2013,110(14):5618
[11]MARKWALD RR,FITZHARRIS TP,MANASEK FJ.Structural development of endocardial cushions[J].Am J Anat,1977,148(1):85
[12]VALCOURT U,KOWANETZ M,NIIMI H,et al.TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition[J].Mol Biol Cell,2005,16(4):1987
[13]XU D,LI N,HE Y,et al.Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors[J].Proc Natl Acad Sci USA,2006,103(49):18733

备注/Memo

备注/Memo:
*郑州大学第一附属医院院内青年创新基金项目
#通信作者,男,1975年1月生,博士,教授,研究方向:心血管病介入治疗,E-mail:yanghaibo1975@126.com
更新日期/Last Update: 2017-03-20